Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹3,733Cr
Rev Gr TTM
Revenue Growth TTM
-4.38%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

NACLIND
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | 27.1 | -20.9 | 2.7 | -23.9 | -23.6 | -13.5 | -24.1 | -26.7 | -55.9 | 38.0 | 3.8 | 18.8 |
| 531 | 404 | 550 | 361 | 446 | 329 | 400 | 294 | 275 | 410 | 412 | 312 |
Operating Profit Operating ProfitCr |
| 11.3 | -7.6 | 5.3 | 1.1 | 2.4 | -1.1 | 9.3 | -9.8 | -36.7 | 8.5 | 9.8 | 2.1 |
Other Income Other IncomeCr | 4 | 3 | 1 | 1 | 4 | 2 | 4 | 2 | 30 | 1 | -17 | 0 |
Interest Expense Interest ExpenseCr | 17 | 18 | 20 | 19 | 19 | 18 | 17 | 15 | 14 | 14 | 13 | 12 |
Depreciation DepreciationCr | 9 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 8 | 7 | 8 | 8 |
| 46 | -51 | 6 | -20 | -11 | -27 | 20 | -47 | -66 | 18 | 6 | -14 |
| 13 | -12 | 2 | -4 | -2 | -6 | 5 | -10 | -16 | 5 | 4 | -3 |
|
Growth YoY PAT Growth YoY% | 64.5 | -355.1 | -86.3 | -196.2 | -126.9 | 45.4 | 265.2 | -127.9 | -454.9 | 162.7 | -82.9 | 72.0 |
| 5.6 | -10.1 | 0.7 | -4.3 | -2.0 | -6.4 | 3.4 | -13.5 | -24.8 | 2.9 | 0.6 | -3.2 |
| 1.6 | -1.8 | 0.2 | -0.7 | -0.4 | -0.9 | 0.7 | -1.7 | -2.3 | 0.6 | 0.1 | -0.5 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| 17.3 | -7.2 | 6.2 | 15.2 | 2.2 | 17.3 | 17.4 | 37.1 | 29.5 | -15.9 | -30.6 | 15.4 |
| 702 | 636 | 679 | 798 | 852 | 946 | 1,079 | 1,493 | 1,923 | 1,762 | 1,297 | 1,409 |
Operating Profit Operating ProfitCr |
| 5.9 | 8.1 | 7.6 | 5.7 | 1.6 | 6.8 | 9.5 | 8.6 | 9.1 | 1.0 | -5.1 | 1.1 |
Other Income Other IncomeCr | 26 | 19 | 41 | 20 | 27 | 8 | 15 | 11 | 11 | 10 | 38 | 14 |
Interest Expense Interest ExpenseCr | 35 | 37 | 38 | 33 | 34 | 29 | 28 | 27 | 47 | 76 | 65 | 53 |
Depreciation DepreciationCr | 25 | 27 | 28 | 20 | 20 | 24 | 25 | 25 | 28 | 27 | 29 | 31 |
| 10 | 11 | 31 | 15 | -13 | 24 | 75 | 100 | 128 | -76 | -119 | -55 |
| 3 | 2 | -1 | 4 | -7 | 7 | 24 | 26 | 34 | -17 | -27 | -10 |
|
| 135.8 | 16.1 | 258.5 | -63.4 | -160.1 | 340.9 | 204.6 | 44.0 | 29.2 | -162.1 | -56.4 | 51.6 |
| 1.0 | 1.3 | 4.3 | 1.4 | -0.8 | 1.6 | 4.3 | 4.5 | 4.5 | -3.3 | -7.5 | -3.1 |
| 0.5 | 0.6 | 1.9 | 0.7 | -0.4 | 0.9 | 2.4 | 3.4 | 4.4 | -2.7 | -4.2 | -2.1 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 16 | 16 | 16 | 16 | 17 | 19 | 20 | 20 | 20 | 20 | 20 | 20 |
| 162 | 170 | 213 | 223 | 247 | 338 | 397 | 469 | 554 | 491 | 407 | 424 |
Current Liabilities Current LiabilitiesCr | 441 | 356 | 368 | 432 | 431 | 553 | 453 | 831 | 1,115 | 1,143 | 727 | 947 |
Non Current Liabilities Non Current LiabilitiesCr | 47 | 69 | 53 | 42 | 27 | 44 | 104 | 196 | 226 | 164 | 109 | 96 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 454 | 416 | 462 | 530 | 555 | 691 | 693 | 1,130 | 1,412 | 1,288 | 706 | 967 |
Non Current Assets Non Current AssetsCr | 211 | 195 | 189 | 183 | 188 | 264 | 283 | 385 | 504 | 530 | 557 | 521 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 40 | 46 | 58 | 24 | 36 | 103 | 83 | -124 | -20 | 50 | 469 |
Investing Cash Flow Investing Cash FlowCr | -18 | -12 | -6 | -14 | -27 | -97 | 14 | -163 | -142 | -38 | 4 |
Financing Cash Flow Financing Cash FlowCr | -27 | -33 | -58 | -11 | -9 | 70 | -113 | 290 | 135 | -22 | -448 |
|
Free Cash Flow Free Cash FlowCr | 24 | 34 | 63 | 25 | 37 | 103 | 83 | -124 | -20 | 11 | 438 |
| 530.6 | 517.4 | 184.8 | 211.6 | -523.9 | 615.5 | 163.5 | -169.3 | -21.5 | -85.6 | -509.0 |
CFO To EBITDA CFO To EBITDA% | 91.6 | 81.6 | 104.4 | 50.4 | 264.8 | 150.2 | 74.0 | -88.3 | -10.6 | 296.1 | -746.0 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 213 | 309 | 438 | 617 | 501 | 430 | 746 | 1,611 | 1,627 | 1,126 | 2,048 |
Price To Earnings Price To Earnings | 26.8 | 31.9 | 13.4 | 53.4 | 0.0 | 25.6 | 14.6 | 22.0 | 17.1 | 0.0 | 0.0 |
Price To Sales Price To Sales | 0.3 | 0.5 | 0.6 | 0.7 | 0.6 | 0.4 | 0.6 | 1.0 | 0.8 | 0.6 | 1.7 |
Price To Book Price To Book | 1.2 | 1.7 | 1.9 | 2.6 | 1.9 | 1.2 | 1.8 | 3.3 | 2.8 | 2.2 | 4.8 |
| 9.0 | 9.1 | 11.2 | 17.0 | 49.9 | 8.3 | 7.7 | 14.5 | 11.8 | 108.6 | -38.0 |
Profitability Ratios Profitability Ratios |
| 33.8 | 36.7 | 38.2 | 33.6 | 29.4 | 29.7 | 29.9 | 25.8 | 24.5 | 22.2 | 26.1 |
| 5.9 | 8.1 | 7.6 | 5.7 | 1.6 | 6.8 | 9.5 | 8.6 | 9.1 | 1.0 | -5.1 |
| 1.0 | 1.3 | 4.3 | 1.4 | -0.8 | 1.6 | 4.3 | 4.5 | 4.5 | -3.3 | -7.5 |
| 12.1 | 11.9 | 16.0 | 10.7 | 4.4 | 8.7 | 16.6 | 12.4 | 13.5 | 0.0 | -6.6 |
| 4.3 | 4.8 | 13.8 | 4.8 | -2.6 | 4.7 | 12.2 | 15.0 | 16.5 | -11.5 | -21.6 |
| 1.1 | 1.4 | 4.9 | 1.6 | -0.9 | 1.8 | 5.2 | 4.8 | 5.0 | -3.2 | -7.3 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
### **Overview**
NACL Industries Limited is an established, integrated agrochemical company founded in **1993** in India. The company specializes in the end-to-end development, manufacturing, and marketing of **crop protection chemicals**, including technical-grade active ingredients (AIs), intermediates, and proprietary formulated products such as insecticides, herbicides, fungicides, and plant growth regulators (PGRs). It operates across three key segments: **Domestic Retail, Institutional (B2B), and Exports**.
In **August 2025**, a pivotal ownership change occurred when **Coromandel International Limited**, a leading agri-solutions provider and part of the prestigious **Murugappa Group (revenue: ₹778 billion)**, acquired majority control of NACL Industries. This strategic acquisition marks a new phase of growth, operational revival, and value creation for NACL.
---
### **Business Segments & Market Presence**
- **Domestic Retail**:
NACL serves over **5 million Indian farmers** through a **direct-to-retail distribution model**, supported by **47 stock points** and **over 12,500 retail outlets** nationwide.
- Offers **66+ branded agrochemical formulations**, with strong market presence in rice, cotton, pulses, oilseeds, and vegetables.
- Key recent launches include **Rozzer (Topramezone SC)** and **Temboguard (Tembotrione SC)** for maize, **Bushi (mite control)**, and **Suraksha SC (lepidopteran pests)**.
- Farmers are engaged through **knowledge delivery programs**, field demonstrations, and the **Krishi Kalyan App**, which provides diagnostics, treatment guidance, and usage data.
- **Export & B2B (Toll Manufacturing)**:
- Exports to **22 countries**, including developed markets like the **USA, Japan, and Australia**, and emerging markets in Asia, Africa, Latin America, and the Middle East.
- Historically, exports accounted for up to **35% of revenue** (FY23), with strong relationships with global MNCs such as **Syngenta, Nissan Chemical, and Saraswati Agro Chemicals**.
- Acts as a **reliable contract manufacturer**, supplying active ingredients and intermediates under long-term partnerships.
- Export segment has shown robust growth, including a **250% volume increase (FY24)** in formulations to Asia and Africa.
---
### **Manufacturing & Capacity**
NACL operates a vertically integrated manufacturing framework with four production units located across **Andhra Pradesh** and **Gujarat**:
- **Srikakulam (AP)**: AI manufacturing (upgraded to 70.1 TPD from 30 TPD); ZLD-compliant.
- **Ethakota (AP)**: Formulation and packaging facility.
- **Dahej (Gujarat)**: Fully operational **6,000 TPA** plant via **NACL Spec-Chem Limited (NSCL)**.
- Future **greenfield site near Visakhapatnam** for fluorinated chemicals is in development.
#### **Current Production Capacities**:
| Segment | Capacity (Annual) |
|--------|-------------------|
| Technical Manufacturing | 17,000 TPA (post-consolidation) |
| Formulation Handling | 12,000 KL (liquids), 5,600 MT (powders), **35,000 MT (granules)** |
| Formulation & Packaging | Up to 53,000 MT/KL combined (Ethakota plant) |
- Capacity utilization currently at **~70%**, with ongoing **de-bottlenecking and expansion projects** to support scale-up.
- Strategic investments aim to expand into **specialty chemicals and advanced intermediates**.
---
### **Research & Development**
NACL’s **R&D Center**, located on a **4-acre campus in Shadnagar, Hyderabad**, is a cornerstone of innovation:
- Employs **~70 scientists** focused on:
- Development of complex chemistries, generic AIs, combination formulations.
- **Fluorination technology** – a **pioneering capability** in India at pilot and lab scale.
- Process optimization, impurity profiling, method validation, and stability studies.
- **Accreditations**:
- **GLP-certified** (OECD-compliant), accepted in USA, EU, Japan, and other OECD countries.
- **ISO 17025:2017** and **DSIR-recognized**.
- **Recent Milestones (Aug 2025)**:
- Developed processes for **4 technical products** (2 commercialized, 2 at pilot stage).
- Commercialized **5 new formulations**, including **Speed (Imidacloprid + Fipronil WG)** and **Carpet (Pyroxasulfone WG)**.
- Filed **2 provisional patents**; over **20 patent applications** filed (Jan 2024).
- Successfully executed **commercial-scale intermediate supply for multinational clients**.
---
### **Subsidiaries & Group Structure**
NACL has a diversified corporate structure with **6 subsidiaries** and 1 associate:
- **NACL Spec-Chem Limited (NSCL)** – Dahej, Gujarat (6,000 TPA AI/intermediates; Rs 300+ crore FY24 revenue).
- **NACL Agri-Solutions Private Limited (NASPL)** – Launched innovative liquid nutrients (Zinc Oxide SC, Boron Ethanolamine). Reported **₹71 lakhs revenue** in FY25 (from ₹2 lakhs).
- **NACL Multichem Private Limited** – Greenfield facility in Srikakulam (38,000 MTPA planned).
- **Nagarjuna Agrichem (Australia) Pty Limited**
- **NACL Industries (Nigeria) Limited** – Incorporated Jan 2023; no capital transferred as of March 2025.
- **LR Research Laboratories Private Limited**
**Associate**: Nasense Labs Private Limited.
Following Coromandel's acquisition, NACL operates under the broader **Murugappa Group**, which includes **Coromandel International, Cholamandalam, CUMI, and CG Power**.
---
### **Strategic Developments & Initiatives**
- **Acquisition Strategy**: Plans to **acquire a controlling stake in a target crop protection company** to build synergies in manufacturing, product portfolio, and market reach.
- **Farmer-Centric Innovation**: R&D and product development driven by field feedback, digital tools, and AI-based customer engagement.
- **Sustainability & Digital Transformation**:
- Embracing **responsible manufacturing, automation, and Zero Liquid Discharge (ZLD)**.
- Launching **biocontrol solutions, liquid nutrient formulations, and digital advisory platforms**.
- Participating in India’s **“Make in India”** mission by developing import-substitute intermediates.
- **Expansion Targets**:
- Entering **new geographies** and strengthening presence in Africa (Nigeria subsidiary), Southeast Asia, and Latin America.
- Scaling **product registrations** – over 100 dossiers submitted in 2024.
- Expanding **greenfield sites in Dahej and Srikakulam**.
---
### **Financial & Operational Performance**
- **FY23 Revenue**: ₹**2,116 crores** (+29% YoY), driven by export growth (+40%), retail expansion (+25%).
- **FY24–25 Challenges**:
- Impacted by **erratic monsoons**, **working capital constraints**, **raw material volatility**, and **global softness in technical demand**.
- Temporary lender restrictions affected procurement and order fulfillment in H2 FY25.
- **Revival Strategy**:
- Completed **capital-intensive revival** with change in promoter group (Coromandel takeover).
- Improved access to credit, operational expertise, and governance.